Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases that share overlapping genetic origins and similar cellular pathologies [1, 2] . Expression of some FTD/ ALS-associated mutated proteins affects glial cells as well as neuronal cells [3] . Thus, the clinical features are severe and often display developmental delay, spasticity, nystagmus, and optic atrophy.
Chromatin-modifying protein/charged multivesicular body protein 2B (CHMP2B) is a component of a protein metabolizing/degradation unit called endosomal sorting complex required for transport-III (ESCRT-III). CHMP2B is involved in the regulation of metabolizing cell surface proteins through the formation of multivesicular bodies (MVBs) [4, 5] . The formation begins from a process in which misfolded and damaged proteins enter endosomes.
The Ile29-to-Val (I29V) mutation of CHMP2B is known to be associated with chromosome 3-linked familial FTD (FTD3) and ALS17 (OMIN Nos. 600795 and 600795, respectively) [6] [7] [8] [9] ; however, the cellular and molecular mechanism underlying FTD3/ALS17 remains to be understood. Cells harboring CHMP2B mutant constructs failed to exhibit differentiated phenotypes with long processes in N1E-115 cells [10] as the neuronal cell model (Fig. 1) . Similarly, cells harboring CHMP2B mutant constructs decreased processes with myelin web-like structures in FBD-102b cells [11] as the oligodendroglial cell model (Fig. 2) . Also, wild type CHMP2B proteins formed MVB-like vesicular structures ( Fig. S1 ) whereas mutant proteins did small protein aggregates (Fig. S2 ) and were mainly localized in ubiquitin-positive ones (Fig. S3) [12] .
In amino acid sequences, the Ile-29 position in human and rodent CHMP2B is far from the positions of the respective mutations associated with FTD3 or ALS17 (Fig. S4) . In addition to information as described above (Fig. S5) , further studies on the relationship between FTD3 and/ or ALS17 mutations and CHMP2B protein properties will allow us to understand how disease mutation causes cellular pathological effects.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.ymgmr.2019.100458. 
